Nancy Stuart
2017
In 2017, Nancy Stuart earned a total compensation of $1.9M as Chief Operating Officer at Concert Pharmaceuticals, a 36% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $183,194 |
|---|---|
| Option Awards | $523,754 |
| Salary | $398,247 |
| Stock Awards | $832,200 |
| Other | $9,906 |
| Total | $1,947,301 |
Stuart received $832.2K in stock awards, accounting for 43% of the total pay in 2017.
Stuart also received $183.2K in non-equity incentive plan, $523.8K in option awards, $398.2K in salary and $9.9K in other compensation.
Rankings
In 2017, Nancy Stuart's compensation ranked 5,634th out of 14,666 executives tracked by ExecPay. In other words, Stuart earned more than 61.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,634 out of 14,666 | 62nd |
Division Manufacturing | 2,038 out of 5,772 | 65th |
Major group Chemicals And Allied Products | 629 out of 2,075 | 70th |
Industry group Drugs | 484 out of 1,731 | 72nd |
Industry Pharmaceutical Preparations | 380 out of 1,333 | 72nd |
Source: SEC filing on May 3, 2018.
Stuart's colleagues
We found two more compensation records of executives who worked with Nancy Stuart at Concert Pharmaceuticals in 2017.